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Signaling between a T cell and an antigen-presenting cell (APC) 
is orchestrated through a bull’s eye–like structure known as the 
immunological synapse. But no one had ever spotted these structures 
in vivo, causing many to wonder whether they are immunology’s 
equivalent of the Loch Ness monster. Synapse devotees can now rest 
easy, thanks to Barcia et al., who provide the first in vivo glimpse of 
these elusive cellular structures on page 2095.
When first described, immunological synapses—their centers rich 
with T cell receptor (TCR)-MHC/peptide complexes and their outer 
rings with stabilizing integrins and adhesion molecules—provided a 
satisfying spatial model of how T cells get activated and signal to 
target APCs. But although these structures formed readily when T cells 
bumped into artificial lipid bilayers or cultured APCs, they have proven 
difficult to capture in real-life settings—in part due to limitations of 
live imaging and the touch-and-go nature of T cell–APC interactions.
Barcia et al. used a well-characterized model of viral brain 
infection in rats to help them pinpoint when and where to look for 
cytotoxic T cells engaging infected brain cells. The use of a 
nonreplicating virus—which infected brain cells but did not destroy 
them—also aided the synapse hunt. Three-dimensional reconstructions of confocal images revealed both 
the polarization of phosphorylated signaling kinases toward the T cell–APC contact site (an early sign 
of T cell activation) and—voilà!—the characteristic bull’s-eye structure of the synapse.
The formation of synapses preceded viral clearance, suggesting that these ordered structures might indeed 
be necessary for T cell activation and subsequent elimination of infected cells. Formal proof of this, however, 
awaits the development of inhibitors or genetic mutations that selectively interfere with synapse formation. At 
least now we can rest assured that synapses really are more than just visually pleasing in vitro phenomena. 
Desperately seeking synapses
The harder a protein is to chop up, say 
Delamarre and colleagues on page 2049, 
the more vigorous an immune response 
it will trigger. This suggests that the most 
durable antigens—or those attached to 
degradation-resistant carrier proteins—
might make the best vaccines.
The correlation between stability 
and immunogenicity may seem coun-
terintuitive, given that the very products 
of lysosomal degradation—antigenic 
peptides or epitopes—bind to class II 
MHC molecules for presentation to 
CD4+ T cells. And many (but not all) in 
vitro studies show that blocking lyso-
somal function in vitro inhibits antigen 
presentation.
To determine which kind of antigen 
elicits the strongest immune response, 
Delamarre et al. stuck identical T or B 
cell epitopes into lysosomal degradation-
resistant and degradation-sensitive ver-
sions of the same protein. Mice 
immunized with the more durable 
versions of the proteins generated more 
robust T cell and antibody responses 
than those immunized with the more 
degradable forms. Stabilizing the degra-
dation-prone antigens using aldehyde 
fixation boosted their immunogenicity.
Antigen-presenting cells did not 
simply have a bigger appetite for the 
more stable form of the protein, as 
both forms were taken up equally well 
by dendritic cells (DCs). Rather, the 
more stable antigens were better re-
tained in DCs as they transited from 
peripheral sites of antigen capture to 
lymph nodes, where they present their 
antigenic cargo to T cells.
This group previously showed that 
DCs express a paucity of proteases com-
pared with macrophages, allowing them 
to degrade internalized proteins more 
slowly and thus retain them longer—
perhaps explaining why DCs are so good 
at disseminating antigens and initiating 
immunity. Thus, both the nature of a 
protein and the cell type it ends up in 
help determine how immune provoking 
that protein will be. 
Protease-resistant proteins (HRP) induce 
more robust T cell proliferation than their 
degradation-sensitive counterparts (apo-HRP).
Tough antigens trigger immunity
LFA-1 (red) molecules surround central TCRs (green) in a 
live synapse.
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